Agile Therapeutics Inventory Turnover Ratio 2013-2023 | AGRX
Agile Therapeutics inventory turnover ratio from 2013 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| Agile Therapeutics Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.003B | $0.020B |
| Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.675B | 5.30 |
| Dr Reddy's Laboratories (RDY) | India | $11.950B | 18.89 |
| Aspen Pharmacare (APNHY) | South Africa | $5.172B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.438B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.194B | 2.49 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.999B | 13.68 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.611B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.482B | 0.00 |
| Generation Bio (GBIO) | United States | $0.208B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.080B | 0.00 |
| Personalis (PSNL) | United States | $0.063B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.031B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.026B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |